Lab-Grown 'Mini Tumors' could personalize pancreatic cancer care

NCT ID NCT06666803

Recruiting now Knowledge-focused Sponsor: IHU Strasbourg Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to grow miniature versions of pancreatic tumors, called organoids, from small biopsy samples taken during routine endoscopic procedures. Researchers will check if these organoids match the genetic makeup of the original tumor. If successful, this approach could allow doctors to test different drugs on a patient's organoids before choosing a treatment. The study involves 60 adults with suspected pancreatic cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could pave the way for personalized drug testing on patient-derived organoids, potentially improving treatment choices for pancreatic cancer.
What could go wrong: This is an early-stage, observational study focused on lab methods, not a treatment trial. It may not lead to direct patient benefits, and organoid growth from small biopsies may fail.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic ductal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PDAC - PANCREATIC DUCTAL ADENOCARCINOMA

Contacts and locations

Locations

Centre d'Endoscopie Digestive
RECRUITING

Strasbourg, France
Department of hepato-gastroenterology
RECRUITING

Strasbourg, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.